Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors Nature Communications Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine CagriSema Demonstrates Weight Loss, Fails to Achieve Primary Endpoint Compared to Tirzepatide HCPLive Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Clinical trials of subcutaneous tirzepatide, retatrutide, and Download Scientific Diagram EASD e Learning Provided by leading diabetes academics